Primidone blocks RIPK1-driven cell death and inflammation
Open Access
- 1 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 28 (5), 1610-1626
- https://doi.org/10.1038/s41418-020-00690-y
Abstract
The receptor-interacting serine/threonine protein kinase 1 (RIPK1) is a key mediator of regulated cell death and inflammation. Recent studies suggest that RIPK1 inhibition would fundamentally improve the therapy of RIPK1-dependent organ damage in stroke, myocardial infarction, kidney failure, and systemic inflammatory response syndrome. Additionally, it could ameliorate or prevent multi-organ failure induced by cytokine release in the context of hyperinflammation, as seen in COVID-19 patients. Therefore, we searched for a RIPK1 inhibitor and present the aromatic antiepileptic and FDA-approved drug primidone (Liskantin (R)) as a potent inhibitor of RIPK1 activation in vitro and in a murine model of TNF alpha-induced shock, which mimics the hyperinflammatory state of cytokine release syndrome. Furthermore, we detected for the first time RIPK1 activation in the respiratory tract epithelium of hospitalized patients who tested positive for SARS-CoV-2 infection. Our data provide a strong rationale for evaluating the drug primidone in conditions of hyperinflammation in humans.Funding Information
- Deutsche Forschungsgemeinschaft (400339789)
- Dr. Werner Jackstädt-Stiftung
- Cancer Research UK (CRM089X)
This publication has 56 references indexed in Scilit:
- Necroptosis, in vivo detection in experimental disease modelsSeminars in Cell & Developmental Biology, 2014
- Regulated cell death and inflammation: an auto-amplification loop causes organ failureNature Reviews Immunology, 2014
- Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or ApoptosisScience, 2014
- Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKLJournal of Biological Chemistry, 2013
- Myocardial ischemia-reperfusion injury: a neglected therapeutic targetJCI Insight, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injuryKidney International, 2012
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 KinaseCell, 2012
- Identification of RIP1 kinase as a specific cellular target of necrostatinsNature Chemical Biology, 2008
- Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling ComplexesCell, 2003